These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29037996)

  • 1. Synthesis, anti-cancer screening and tyrosyl-DNA phosphodiesterase 1 (Tdp1) inhibition activity of novel piperidinyl sulfamides.
    Jun JH; Kumar V; Dexheimer TS; Wedlich I; Nicklaus MC; Pommier Y; Malhotra SV
    Eur J Pharm Sci; 2018 Jan; 111():337-348. PubMed ID: 29037996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents.
    Zhang XR; Wang HW; Tang WL; Zhang Y; Yang H; Hu DX; Ravji A; Marchand C; Kiselev E; Ofori-Atta K; Agama K; Pommier Y; An LK
    J Med Chem; 2018 Nov; 61(22):9908-9930. PubMed ID: 30336023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of aryliden- and hetarylidenfuranone derivatives of usnic acid as highly potent Tdp1 inhibitors.
    Zakharova O; Luzina O; Zakharenko A; Sokolov D; Filimonov A; Dyrkheeva N; Chepanova A; Ilina E; Ilyina A; Klabenkova K; Chelobanov B; Stetsenko D; Zafar A; Eurtivong C; Reynisson J; Volcho K; Salakhutdinov N; Lavrik O
    Bioorg Med Chem; 2018 Aug; 26(15):4470-4480. PubMed ID: 30076000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of furanotriterpenoids from betulin and evaluation of Tyrosyl-DNA phosphodiesterase 1 (Tdp1) inhibitory properties of new semi-synthetic triterpenoids.
    Tolmacheva I; Eroshenko D; Chernyshova I; Nazarov M; Lavrik O; Grishko V
    Eur J Med Chem; 2024 Oct; 276():116724. PubMed ID: 39079310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of indenoisoquinolines that inhibit both tyrosyl-DNA phosphodiesterase I (Tdp1) and topoisomerase I (Top1).
    Conda-Sheridan M; Reddy PV; Morrell A; Cobb BT; Marchand C; Agama K; Chergui A; Renaud A; Stephen AG; Bindu LK; Pommier Y; Cushman M
    J Med Chem; 2013 Jan; 56(1):182-200. PubMed ID: 23259865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of Methoxy-, Methylenedioxy-, Hydroxy-, and Halo-Substituted Benzophenanthridinone Derivatives as DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors and Their Biological Activity for Drug-Resistant Cancer.
    Hu DX; Tang WL; Zhang Y; Yang H; Wang W; Agama K; Pommier Y; An LK
    J Med Chem; 2021 Jun; 64(11):7617-7629. PubMed ID: 34008967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deoxycholic acid as a molecular scaffold for tyrosyl-DNA phosphodiesterase 1 inhibition: A synthesis, structure-activity relationship and molecular modeling study.
    Salomatina OV; Popadyuk II; Zakharenko AL; Zakharova OD; Chepanova AA; Dyrkheeva NS; Komarova NI; Reynisson J; Anarbaev RO; Salakhutdinov NF; Lavrik OI; Volcho KP
    Steroids; 2021 Jan; 165():108771. PubMed ID: 33221302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Deoxycholic Acid Derived Tyrosyl-DNA Phosphodiesterase 1 Inhibitors Also Inhibit Tyrosyl-DNA Phosphodiesterase 2.
    Salomatina OV; Dyrkheeva NS; Popadyuk II; Zakharenko AL; Ilina ES; Komarova NI; Reynisson J; Salakhutdinov NF; Lavrik OI; Volcho KP
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Class of Tyrosyl-DNA Phosphodiesterase 1 Inhibitors That Contains the Octahydro-2
    Li-Zhulanov NS; Zakharenko AL; Chepanova AA; Patel J; Zafar A; Volcho KP; Salakhutdinov NF; Reynisson J; Leung IKH; Lavrik OI
    Molecules; 2018 Sep; 23(10):. PubMed ID: 30261631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of novel tyrosyl-DNA phosphodiesterase 1 inhibitors with a benzopentathiepine moiety.
    Zakharenko A; Khomenko T; Zhukova S; Koval O; Zakharova O; Anarbaev R; Lebedeva N; Korchagina D; Komarova N; Vasiliev V; Reynisson J; Volcho K; Salakhutdinov N; Lavrik O
    Bioorg Med Chem; 2015 May; 23(9):2044-52. PubMed ID: 25819333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel group of tyrosyl-DNA-phosphodiesterase 1 inhibitors based on disaccharide nucleosides as drug prototypes for anti-cancer therapy.
    Komarova AO; Drenichev MS; Dyrkheeva NS; Kulikova IV; Oslovsky VE; Zakharova OD; Zakharenko AL; Mikhailov SN; Lavrik OI
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1415-1429. PubMed ID: 30191738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Arylidenethioxothiazolidinones as inhibitors of tyrosyl-DNA phosphodiesterase I.
    Sirivolu VR; Vernekar SK; Marchand C; Naumova A; Chergui A; Renaud A; Stephen AG; Chen F; Sham YY; Pommier Y; Wang Z
    J Med Chem; 2012 Oct; 55(20):8671-84. PubMed ID: 23006064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New 5-Hydroxycoumarin-Based Tyrosyl-DNA Phosphodiesterase I Inhibitors Sensitize Tumor Cell Line to Topotecan.
    Khomenko TM; Zakharenko AL; Kornienko TE; Chepanova AA; Dyrkheeva NS; Artemova AO; Korchagina DV; Achara C; Curtis A; Reynisson J; Volcho KP; Salakhutdinov NF; Lavrik OI
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoadamantanes containing monoterpene-derived fragments as potent tyrosyl-DNA phosphodiesterase 1 inhibitors.
    Ponomarev KY; Suslov EV; Zakharenko AL; Zakharova OD; Rogachev AD; Korchagina DV; Zafar A; Reynisson J; Nefedov AA; Volcho KP; Salakhutdinov NF; Lavrik OI
    Bioorg Chem; 2018 Feb; 76():392-399. PubMed ID: 29248742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors.
    Dexheimer TS; Gediya LK; Stephen AG; Weidlich I; Antony S; Marchand C; Interthal H; Nicklaus M; Fisher RJ; Njar VC; Pommier Y
    J Med Chem; 2009 Nov; 52(22):7122-31. PubMed ID: 19883083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel high-throughput electrochemiluminescent assay for identification of human tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors and characterization of furamidine (NSC 305831) as an inhibitor of Tdp1.
    Antony S; Marchand C; Stephen AG; Thibaut L; Agama KK; Fisher RJ; Pommier Y
    Nucleic Acids Res; 2007; 35(13):4474-84. PubMed ID: 17576665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a putative Tdp1 inhibitor (CD00509) by in vitro and cell-based assays.
    Dean RA; Fam HK; An J; Choi K; Shimizu Y; Jones SJ; Boerkoel CF; Interthal H; Pfeifer TA
    J Biomol Screen; 2014 Dec; 19(10):1372-82. PubMed ID: 25117203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The First Berberine-Based Inhibitors of Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), an Important DNA Repair Enzyme.
    Gladkova ED; Nechepurenko IV; Bredikhin RA; Chepanova AA; Zakharenko AL; Luzina OA; Ilina ES; Dyrkheeva NS; Mamontova EM; Anarbaev RO; Reynisson J; Volcho KP; Salakhutdinov NF; Lavrik OI
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy.
    Dexheimer TS; Antony S; Marchand C; Pommier Y
    Anticancer Agents Med Chem; 2008 May; 8(4):381-9. PubMed ID: 18473723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dehydroabietylamine-based thiazolidin-4-ones and 2-thioxoimidazolidin-4-ones as novel tyrosyl-DNA phosphodiesterase 1 inhibitors.
    Kovaleva K; Mamontova E; Yarovaya O; Zakharova O; Zakharenko A; Lavrik O; Salakhutdinov N
    Mol Divers; 2021 Nov; 25(4):2389-2397. PubMed ID: 32833106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.